December 14-15, 2017

Medtech Impact Expo & Conference

Venetian / Palazzo Resort

Las Vegas, NV

(561) 893-8633

info@medtechimpact.com

Month: March 2017

Tarsus Medical Group announces keynotes for MedTech Impact Expo & Conference — an event that reinforces the critical connection between technology and healthcare

March 24, 2017 (Boca Raton, FL) –

Tarsus Medical has announced the MedTech Impact Expo & Conference, taking place December 14-15, 2017 in Las Vegas at The Venetian/Palazzo Resort. This event is designed to assist healthcare practitioners and professionals to better serve their patients through the use of medical technology and devices, while understanding the transformative effects of newly developed products and equipment. Speakers and sessions will educate attendees on groundbreaking scientific research and education, supplemented by the most progressive equipment and medical technology. The conference takes place alongside another of Tarsus Medical Group’s leading healthcare industry events, The A4M World Congress.

The conference opening keynote on Thursday, December 14 will feature Pablos Holman, a self-described ‘futurist, inventor, and notorious hacker.’ Holman’s resume includes global consultations on invention and design projects that assimilate the most recent and cutting-edge technologies, including the world’s smallest PC, 3-D printers, and the Hackerbot: a Wi-Fi seeking robot. Robin Farmanfarmaian, an entrepreneur, founder, professional speaker, and author working with companies in cutting-edge technology poised to impact hundreds of millions of people will deliver Friday’s keynote, “The Patient as CEO,” focusing on patient empowerment and engagement through technological advancements set to fundamentally change healthcare, and allow patients to be in control of their own health.

About MedTech Impact:

MedTech Impact Expo & Conference brings together medical providers, hospital administrators, technology developers and manufacturers, entrepreneurs, and investors for a two-day dialogue that focuses on the advent and proliferation of medical technology; assessing its current developments, in addition to its future impact on the transformations in healthcare. Healthcare practitioners and professionals will be introduced to the latest technologies, products, and services that can track patient progress, assist with diagnoses, prevent and manage disease, and improve overall patient care.

The conference program will provide sessions that offer scientifically-based research and insight from thought-leaders in the field, coupled with lessons learned through case-studies and peer-to-peer sharing of best-practices and protocols. Attendees will ultimately gain an increased understanding of the ways in which to harness technology, in order to increase practice efficiency and improve patient care. For more information, visit www.medtechimpact.com.

Smartphones: Accurately Testing Sperm Count

Smartphones now have the capability to accurately test for sperm count, led by a team of researchers at Harvard who work on developing new tools for patient care. According to the World Health Organization, low sperm count is one of the primary markers for male infertility, which is a globally neglected health issue.

The scientists have developed a rapid infertility diagnostic tool that attaches to a smartphone; the attachment itself is compatible with an app created to count the numbers of sperm and measure motility: markers for infertility. While the team at Harvard is not the first to develop an at-home fertility test designed for men, they are the first to successfully determine sperm concentration in addition to motility.

The process is simple: a small semen sample is loaded onto a disposable microchip, which is then placed into the cellphone attachment through a slot. The attachment turns the phone’s camera into a microscope. After the sample is loaded and the app is run—which allows users to see a video of the sample—the record button is pressed, and the app subsequently analyzes the video to identify sperm cells, and track their movements.

Scientists did a side-by-side comparison of the smartphone sperm tracker with current lab equipment, analyzing over 350 semen samples of both infertile and fertile men. The smartphone system’s identification accuracy was 98 percent. The group also assessed whether an untrained user, with no scientific background, could successfully and easily operate the app. The results, published in the journal Science Translational Medicine on Wednesday, indicated that both untrained and trained users could operate the at-home test without difficulty.

While the cell phone attachment is engineered to work with Android devices, the team is currently creating a version compatible with iPhones. The device costs only $5 to make in the lab, and the low cost could ultimately help provide necessary infertility care—particularly in developing nations, which often lack the resources for currently available diagnostics.

While the device has been designed to test for male infertility, its creators believe it could also help men who have recently undergone a vasectomy. After the procedure, physicians urge men to have their sperm count tested, in order to tell whether the procedure was successful. Yet many men do not return to a clinic and have their samples tested.

Next steps are receiving FDA approval, starting a company, and beginning mass production of the devices, which could likely be available to customers for below 50.00 dollars. In the future, it is possible that fertility tests for men will be as easy and commonplace as at-home pregnancy tests for women.

Help & Hope for the Hearing-Impaired

Recently emerging advancements in the field of medical technology have offered new hope to those who have historically suffered from profound hearing loss.

Specific hearing implants—including cochlear and/or auditory brainstem implants—have ‘revolutionized’ the overall management of hearing loss and impairment. While these surgically implanted devices do not actually amplify sounds like conventionally created hearing aids, they instead provide users with a sense of sound through direct stimulation of the hearing nerves, or the part of the brain involved with hearing.

The implementation of cochlear implants allows patients to both hear and localize sounds as well as someone with healthy hearing; moreover, recent improvements in the technology include more aesthetic & visually discreet models, in addition to wireless accessories that allow individuals to stream sound inputs from phone clips or television: directly to the sound processors.

These hearing devices can assist hearing-impaired people successfully integrate into society. Moreover, there is a wealth of evidence that suggests the majority of deaf children who receive bilateral cochlear implants before age one can ultimately develop as normally as normal-hearing children.

Studies indicate that early intervention and treatment improves overall outcomes, as hearing objectively plays a critical role in the development of speech, coupled with learning and communication skills. Further research demonstrates that children born with hearing loss who receive late intervention receive lower academic test scores than their peers with normal hearing.

Researchers and physicians both stress the importance of early detection and treatment of hearing loss, which should also be a crucial priority in older adults and eldercare. If a patient has already been diagnosed with dementia and/or depression, hearingimpairment can serve to exacerbate and accelerate those conditions. Furthermore, hearing-impaired individuals are less aware of their surroundings, which leads to safety implications.